[Digoxin in treatment of chronic insufficiency and changes of functional state of the pancreas].
The article challenges the issue of combined damage of the cardiovascular and gastroenterological systems. It is recommended differentially manage patients with chorine heart insufficiency and prevalence of systolic or diastolic components of their blood pressure. The authors also consider influence of the treatment on a congestive pancreas. Prevalence of the systolic heart insufficiency (ventricular ejection factor less than 40%) have been observed among patients by the authors; digoxin have been found to be effective in treatment of patients with chronic heart insufficiency and congestive pancreas. Enhancement of left ventricular ejection factor and improvement of ultrasound characteristics of the pancreas have been observed following the treatment.
Zaïka
A V
AV
Zaïka
I V
IV
D000681:Amylases / Q000097:blood; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003971:Diastole / Q000187:drug effects / Q000502:physiology; D004077:Digoxin / Q000627:therapeutic use*; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008049:Lipase / Q000097:blood; D008297:Male; D050500:Pancreatitis, Chronic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology*; D015995:Prevalence; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology; D013599:Systole / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D014463:Ultrasonography; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
D002316:Cardiotonic Agents; D004077:Digoxin; D008049:Lipase; D000681:Amylases